
    
      The purpose of this study is to evaluate the safety and efficacy of adalimumab and to
      determine how well it works in the treatment of adults with moderate to severe plaque
      psoriasis in the Chinese population. Psoriasis is a chronic immunologic disease characterized
      by marked inflammation and thickening of the epidermis that result in thick, scaly plaques
      involving the skin.
    
  